CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 71  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1106
LYS 10.0360
GLU 20.0334
LEU 30.0594
ARG 40.0841
CYS 50.0431
GLN 60.0478
CYS 70.0824
ILE 80.0387
LYS 90.1106
THR 100.0161
TYR 110.0023
SER 120.0113
LYS 130.0157
PRO 140.0129
PHE 150.0055
HIS 160.0089
PRO 170.0103
LYS 180.0125
PHE 190.0103
ILE 200.0041
LYS 210.0082
GLU 220.0166
LEU 230.0164
ARG 240.0291
VAL 250.0157
ILE 260.0246
GLU 270.0114
SER 280.0210
GLY 290.0808
PRO 300.0462
HIS 310.0232
CYS 320.0128
ALA 330.0107
ASN 340.0176
THR 350.0112
GLU 360.0087
ILE 370.0034
ILE 380.0173
VAL 390.0084
LYS 400.0052
LEU 410.0100
SER 420.0104
ASP 430.0147
GLY 440.0117
ARG 450.0026
GLU 460.0113
LEU 470.0108
CYS 480.0131
LEU 490.0044
ASP 500.0027
PRO 510.0082
LYS 520.0149
GLU 530.0062
ASN 540.0060
TRP 550.0054
VAL 560.0041
GLN 570.0064
ARG 580.0021
VAL 590.0045
VAL 600.0019
GLU 610.0040
LYS 620.0085
PHE 630.0054
LEU 640.0143
LYS 650.0176
ARG 660.0089
ALA 670.0226
GLU 680.0212
ASN 690.0191

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.